(Q37350526)

19 August 2017

Competing causes of death from a randomized trial of extended adjuvant endocrine therapy for breast cancer (English)

1 reference

19 August 2017

randomized experiment

1 reference

1 reference

6

Hyman B Muss

1 reference

19 August 2017

5

James N Ingle

1 reference

19 August 2017

Judith-Anne W Chapman

1

1 reference

19 August 2017

Daniel Meng

2

1 reference

19 August 2017

Lois Shepherd

3

1 reference

19 August 2017

Wendy Parulekar

4

1 reference

19 August 2017

Michael Palmer

7

1 reference

19 August 2017

Changhong Yu

8

1 reference

19 August 2017

Paul E Goss

9

1 reference

19 August 2017

language of work or name

English

0 references

publication date

12 February 2008

1 reference

Journal of the National Cancer Institute

19 August 2017

1 reference

19 August 2017

100

1 reference

19 August 2017

252-260

1 reference

19 August 2017

4

1 reference

Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials

19 August 2017

randomized experiment

0 references

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2745611

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2745611

A note on competing risks in survival data analysis

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2745611

New prognostic factors for breast cancer recurrence

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2745611

Competing risks analysis of patients with osteosarcoma: a comparison of four different approaches

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2745611

Computer program to assist in making decisions about adjuvant therapy for women with early breast cancer

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2745611

Estimation of failure probabilities in the presence of competing risks: new representations of old estimators

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2745611

The relationship between prognostic and predictive factors in the management of breast cancer

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2745611

Kaplan-Meier, marginal or conditional probability curves in summarizing competing risks failure time data?

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2745611

A review and critique of some models used in competing risk analysis

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2745611

Prognostic and predictive factors in breast cancer by immunohistochemical analysis.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2745611

The Analysis of Failure Times in the Presence of Competing Risks

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2745611

Ascertaining prognosis for breast cancer in node-negative patients with innovative survival analysis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2745611

Randomized trial of letrozole following tamoxifen as extended adjuvant therapy in receptor-positive breast cancer: updated findings from NCIC CTG MA.17.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2745611

A new look at the statistical model identification

2 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1093%2FJNCI%2FDJN014

Estimating the Dimension of a Model

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1093%2FJNCI%2FDJN014

Improved methodology for analyzing local and distant recurrence

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/18270335

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Proposal for standardized definitions for efficacy end points in adjuvant breast cancer trials: the STEEP system

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/18270335

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Competing causes of death for primary breast cancer

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/18270335

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1093/JNCI/DJN014

1 reference

19 August 2017

1 reference

19 August 2017

1 reference